Synthesis of aminocyanopyrazoles via a multi-component reaction and anti-carbonic anhydrase inhibitory activity of their sulfamide derivatives against cytosolic and transmembrane isoforms

References

• Zhu J, Bienayme H. Multicomponent Reactions. Wiley-VCH, Verlag GmbH & Co.KgaA: Weinheim, 2005: 311–341.
   Google Scholar
• Hulme C, Gore V. “Multi-component reactions: emerging chemistry in drug discovery” ‘from xylocain to crixivan’. Curr Med Chem 2003;10:51–80.
   PubMed Web of Science ®Google Scholar
• Yamada T, Ichino T, Hanyu M, Ninomiya D, Yanagihara R, Miyazawa T et al. A novel intramolecular hydrogen bonding between a side-chain pyridine ring and an amide hydrogen of the peptide backbone in tripeptides containing the new amino acid, alpha,alpha-di(2-pyridyl)glycine. Org Biomol Chem 2004;2:2335–2339.
   Google Scholar
• Anderson JD, Cottam HB, Larson SB, Nord LD, Revankar GR, Robins RK. Synthesis of certain pyrazolo[3,4-d] pyrimidin-3-one nucleoside. J Heterocyclic Chem 1990; 27: 439–453.
   Web of Science ®Google Scholar
• Petrie CR, Cottam HB, Mekernam PA, Robins RK, Revankar GR. Synthesis and biological activity of 6-azacadeguomycin and certain 3,4,6-trisubstituted pyrazolo[3, 4-d] pyridine ribonucleosides. J Med Chem 1985; 28: 1010–1016
   PubMed Web of Science ®Google Scholar
• Allouche F, Chabchoub F, Salem M, Kirsch G. Synthesis of New Pyrazolopyrimidinedithiones and Pyrazolopyrimidinephosphines from Aminocyanopyrazoles. Synthetic Commun 2011; 41: 1500–1507.
   Web of Science ®Google Scholar
• Gupta S, Rodrigues LM, Esteves AP, Oliveira-Campos AM, Nascimento MS, Nazareth N et al. Synthesis of N-aryl-5-amino-4-cyanopyrazole derivatives as potent xanthine oxidase inhibitors. Eur J Med Chem 2008;43:771–780.
   PubMed Web of Science ®Google Scholar
• Ranjana A, Vinod K, Rajiv K, Shiv PS. Approaches towards the synthesis of 5-aminopyrazoles. J Org Chem 2011; 7: 179–197.
   Google Scholar
• Aymn ER, Mohamed IH, Randa EAM, Jehan AM, Farouk MEAM. Synthesis and antiviral evaluation of some new pyrazole and fused pyrazolopyrimidine derivatives. Bioorg Med Chem 2008; 16:7102–7106.
   PubMed Web of Science ®Google Scholar
• Kunal N, Gurinderdeep S, Anil T, Amit A, Sameer S, Raj K, Uttam CB, Prabhakar KV, Naresh KS, Manish KG, Om PS, Dhar KL. A rational approach for the design and synthesis of 1-acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles as a new class of potential non-purine xanthine oxidase inhibitors. Bioorg Med Chem 2011; 19: 1950–1958.
   Google Scholar
• Nesrin GK, Samiye Y, Esra K, Umut S, Ozen O, Gulberk U, Erdem Y, Engin K, Akgul Y, Altan B. A new therapeutic approach in Alzheimer disease: Some novel pyrazoles derivatives as dual MAO-B inhibitors and antiinflammatory analgesics. Bioorg Med Chem 2007; 15: 5775–5786.
   Google Scholar
• Smyth LA, Matthews TP, Horton PN, Hursthouse MB, Collins I. Divergent cyclisations of 2-(5-amino-4-carbamoyl-1H-pyrazol-3-yl)acetic acids with formyl and acetyl electrophiles. Tetrahedron 2007; 63: 9627–9634.
   Web of Science ®Google Scholar
• Schenone S, Brullo C, Bruno O, Bondavalli F, Mosti L, Maga G et al. Synthesis, biological evaluation and docking studies of 4-amino substituted 1H-pyrazolo[3,4-d]pyrimidines. Eur J Med Chem 2008;43:2665–2676.
   PubMed Web of Science ®Google Scholar
• Daniels RN, Kim K, Lebois EP, Muchalski H, Hughes M, Lindsley CW. Microwave-assisted protocols for the expedited synthesis of pyrazolo[1,5-a] and [3,4-d]pyrimidines. Tetrahedron Lett 2008; 49: 305–310.
   Web of Science ®Google Scholar
• Rashad AE, Hegab MI, Abdel-Megeid RE, Micky JA, Abdel-Megeid FME. Synthesis and antiviral evaluation of some new pyrazole and fused pyrazolopyrimidine derivatives. Bioorg Med Chem 2008; 16: 7102–7106.
   PubMed Web of Science ®Google Scholar
• Guerrera F, Sarvà MC, Siracusa MA, Caruso A, Leone MG, Cutuli V et al. Synthesis and pharmacological properties of 3-alkylthio derivatives of isothiazolothieno-1,2,3-triazine. Farmaco 1991;46:33–44.
   Google Scholar
• El-Saghier AMM. Asimple synthesis of some new thienopyridine and Thieno- pyrimidine derivatives. Molecules 2002; 7: 756–766.
   Web of Science ®Google Scholar
• Blanco G, Quintela JM, Peinador C. Synthesis of new heteroaromatic nitrogen ligands : Pyrimido[4’’,5’’: 4’,5’]thieno[3, 2-d]1,2,3–triazines. J Heterocyclic Chem 2006; 43: 1051–1056.
   Google Scholar
• Thomae D, Perspicace E, Hesse S, Kirsch G, Seck P. Synthesis of substituted[1,3] thiazolo [4, 5-b] pyridines and thiazolo [1,3][4, 5-b] triazines. Tetrahedron 2008; 64: 9309–9314.
   Web of Science ®Google Scholar
• Diana P, Barraja P, Lauria A, Montalbano A, Almerico AM, Dattolo G et al. Pyrrolo[2,1-d][1,2,3,5]tetrazine-4(3H)-ones, a new class of azolotetrazines with potent antitumor activity. Bioorg Med Chem 2003;11:2371–2380.
   PubMed Web of Science ®Google Scholar
• Colomer JP, Moyano EL. New application of heterocyclic diazonium salts. Synthesis of pyrazolo[3,4-d][1,2,3]triazin-4-ones and imidazo[4,5-d][1,2,3]triazin-4-ones. Tetrahedron Lett 2011; 52: 1561–1565.
   Web of Science ®Google Scholar
• Thomae D, Perspicace E, Hesse S, Kirsch G, Seck P. Synthesis of substituted[1,3] thiazolo [4, 5-b] pyridines and thiazolo [1,3][4, 5-b] triazines. Tetrahedron 2008; 64: 9309–9314.
   Web of Science ®Google Scholar
• Domarkas J, Dudouit F, Williams C, Qiyu Q, Banerjee R, Brahimi F et al. The combi-targeting concept: synthesis of stable nitrosoureas designed to inhibit the epidermal growth factor receptor (EGFR). J Med Chem 2006;49:3544–3552.
   PubMed Web of Science ®Google Scholar
• Hess S, Perspicace E, Kirsch G. Microwave-assisted synthesis of 2-aminothiophene-3-carboxylic acid derivatives, 3H-thieno[2,3-d] pyrimidin-4-one and 4-chlorothieno[2,3-d] pyrimidine. Tetrahedron Lett 2007; 48: 5261–5264.
   Google Scholar
• Davoodnia A, Rahimizadeh M, Rivadeh Sh, Bakavoli M, Roshani M. Synthesis of new substituted pyrazolo [3,4-d] pyrimidin-4-ones under microwave irradiation. Indian J Heterocylic Chem 2006; 16: 151–154.
   Google Scholar
• Cheng CC, Rolande KR. Potential purine antagonists. VI. Synthesis of-1-alkyl and-1-aryl-4-substituted pyrazolo[3, 4-d]pyrimidines 1956; 21: 1240–1256.
   Google Scholar
• Press JB, Eudy NH, Morthon GO. Aryl coupling reactions of pyrazolo[3, 4-d] pyrimidin-4-yl radicals. J Org Chem 1983; 48: 4605–4611.
   Google Scholar
• Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–181.
   PubMed Web of Science ®Google Scholar
• Neri D, Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 2011;10:767–777.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibitors. Bioorg Med Chem Lett 2010;20:3467–3474.
   PubMed Web of Science ®Google Scholar
• Pastorekova S, Parkkila S, Pastorek J, Supuran CT. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. J Enzyme Inhib Med Chem 2004;19:199–229.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibitors and activators for novel therapeutic applications. Future Med Chem 2011;3:1165–1180.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Bacterial carbonic anhydrases as drug targets: toward novel antibiotics? Front Pharmacol 2011;2:34.
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A, Casini A. Carbonic anhydrase inhibitors. Med Res Rev 2003;23:146–189.
   PubMed Web of Science ®Google Scholar
• Temperini C, Scozzafava A, Vullo D, Supuran CT. Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with l- and d-histidine and crystallographic analysis of their adducts with isoform II: engineering proton-transfer processes within the active site of an enzyme. Chemistry 2006;12:7057–7066.
   PubMed Web of Science ®Google Scholar
• Carta F, Temperini C, Innocenti A, Scozzafava A, Kaila K, Supuran CT. Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule. J Med Chem 2010;53:5511–5522.
   PubMed Web of Science ®Google Scholar
• Maresca A, Temperini C, Vu H, Pham NB, Poulsen SA, Scozzafava A et al. Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors. J Am Chem Soc 2009;131:3057–3062.
   PubMed Web of Science ®Google Scholar
• Maresca A, Temperini C, Pochet L, Masereel B, Scozzafava A, Supuran CT. Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins. J Med Chem 2010;53:335–344.
   PubMed Web of Science ®Google Scholar
• Touisni N, Maresca A, McDonald PC, Lou Y, Scozzafava A, Dedhar S et al. Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors. J Med Chem 2011;54:8271–8277.
   PubMed Web of Science ®Google Scholar
• Alp C, Maresca A, Alp NA, Gültekin MS, Ekinci D, Scozzafava A et al. Secondary/tertiary benzenesulfonamides with inhibitory action against the cytosolic human carbonic anhydrase isoforms I and II. J Enzyme Inhib Med Chem 2012.
   Google Scholar
• Khalifah RJ. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem 1971, 246:2561–2573.
   PubMed Web of Science ®Google Scholar
• Fabrizi F, Mincione F, Somma T, Scozzafava G, Galassi F, Masini E et al. A new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology. J Enzyme Inhib Med Chem 2012;27:138–147.
   PubMed Web of Science ®Google Scholar
• Baranauskiene L, Hilvo M, Matuliene J, Golovenko D, Manakova E, Dudutiene V et al. Inhibition and binding studies of carbonic anhydrase isozymes I, II and IX with benzimidazo[1,2-c][1,2,3]thiadiazole-7-sulphonamides. J Enzyme Inhib Med Chem 2010;25:863–870.
   PubMed Web of Science ®Google Scholar
• Maresca A, Vullo D, Scozzafava A, Manole G, Supuran CT. Inhibition of the beta-class carbonic anhydrases from Mycobacterium tuberculosis with carboxylic acids. J Enzyme Inhib Med Chem 2012.
   Google Scholar
• Maresca A, Vullo D, Scozzafava A, Supuran CT. Inhibition of the alpha- and beta- carbonic anhydrases from the gastric pathogen Helicobacter pylori with anions. J Enzyme Inhib Med Chem 2012.
   Google Scholar
• Alterio V, Di Fiore A, D’Ambrosio K, Supuran CT, De Simone G. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev 2012;112:4421–4468.
   PubMed Web of Science ®Google Scholar
• Okada M, Iwashita S, Koizumi N. Efficient general method for sulfamoylation of a hydroxyl group. Tetrahedron Lett 2000, 41:7047–7050.
   Google Scholar